Skip to main content
39°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about IONS
Recent news which mentions IONS
< Previous
1
2
3
4
5
Next >
Biogen Announces Additional Cost Cutting Initiatives, Chops Certain Stroke, Gene Therapy Programs
April 25, 2023
Tickers
BIIB
IONS
Tags
Market News
IONS
BIIB
From
Benzinga
3 Biotech Stocks to Sell Before They’re 6 Feet Under
April 24, 2023
Tickers
ACRS
AMRS
IONS
Tags
AMRS
ACRS
NASDAQ:AMRS,NASDAQ:ACRS,NASDAQ:IONS
From
InvestorPlace
AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression
April 24, 2023
Tickers
AZN
AZNCF
IONS
Tags
News
Briefs
Large Cap
From
Benzinga
Could This Rare-Disease Drug Candidate Become a Blockbuster?
April 19, 2023
Tickers
AZN
IONS
Tags
Recent Press Releases
Market News
AZN
From
Motley Fool
Analyst Upgrades Arrowhead Pharma Citing 'Attractive Risk/Reward'
April 12, 2023
Tickers
ALNY
ARWR
IONS
MRNA
Tags
Trading Ideas
Health Care
NVO
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
April 11, 2023
Tickers
IONS
Tags
Benzinga
Market News
Analyst Ratings
From
Benzinga
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
March 27, 2023
Tickers
AZN
AZNCF
BXRX
IONS
Tags
Market News
AZNCF
AZN
From
Benzinga
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
March 23, 2023
Tickers
BIIB
IONS
Tags
Market News
IONS
General
From
Benzinga
Analyst Ratings for Ionis Pharmaceuticals
March 21, 2023
Tickers
IONS
Tags
Market News
Benzinga
Analyst Ratings
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
March 21, 2023
Tickers
ADC
AIZ
ALLO
ALNY
Tags
CYTH
IMO
RRC
From
Benzinga
Wall Street predicts approval for another ALS drug
March 21, 2023
Tickers
AMLX
BIIB
IONS
Tags
JP:4523
BIIB
AMLX
From
MarketWatch
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
March 16, 2023
Tickers
BIIB
IONS
Tags
Trading Ideas
Health Care
News
From
Benzinga
Ionis Pharmaceuticals's Earnings Outlook
February 21, 2023
Tickers
IONS
Tags
BZI/EP
IONS
Market News
From
Benzinga
Analyst Says Ionis' Additional Hereditary Angioedema Study Data Supports 'Highly Competitive Profile'
February 21, 2023
Tickers
IONS
Tags
Biotech
Benzinga
Briefs
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
January 19, 2023
Tickers
IONS
Tags
Analyst Ratings
BZI/AAR
IONS
From
Benzinga
EXAS Nears Key Buy Signal in Active Biotech ETF ARKG
January 11, 2023
Tickers
ARKG
EXAS
IONS
PACB
Tags
active biotech ETF
ARK Invest
biotech
From
ETF Trends
The Latest Analyst Ratings for Ionis Pharmaceuticals
December 21, 2022
Tickers
IONS
Tags
Benzinga
Market News
IONS
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
December 21, 2022
Tickers
ADPT
AIMC
AMV
APPN
Tags
ZIMV
MTB
LIVN
From
Benzinga
Ionis Pharmaceuticals Earnings Perspective: Return On Capital Employed
December 13, 2022
Tickers
IONS
Tags
Market News
Benzinga
Earnings
From
Benzinga
Gene Deal Adds New Dimension to Biotech ETF SBIO
November 16, 2022
Tickers
ALPS
IONS
SBIO
Tags
SS&C
ETF Building Blocks Channel
IONS
From
ETF Trends
4 Analysts Have This to Say About Ionis Pharmaceuticals
November 10, 2022
Tickers
IONS
Tags
Benzinga
Market News
Analyst Ratings
From
Benzinga
Phillips 66 To Rally 25%? Here Are 5 Other Price Target Changes For Thursday
November 10, 2022
Tickers
HCAT
IONS
PSX
RSKD
Tags
Analyst Ratings
RSKD
Price Target Changes
From
Benzinga
Ionis Regains Rights To Thrombosis Candidate From Bayer
November 04, 2022
Tickers
BAYRY
BAYZF
IONS
Tags
Market News
BAYRY
IONS
From
Benzinga
3 Biotech Stocks to Sell in October
September 29, 2022
Tickers
GILD
GLPG
ILMN
IONS
Tags
ILMN
Stocks to Sell
GILD
From
InvestorPlace
AstraZeneca Pulls Plug On Ionis Pharma-Partnered Cholesterol Med
September 23, 2022
Tickers
AZN
AZNCF
IONS
Tags
Market News
AZN
why it's moving
From
Benzinga
This Stock Has Delivered a Gain of 100% Over the Past 3 Months. Can You Still Buy?
September 12, 2022
Tickers
AMLX
BIIB
IONS
Tags
Market News
Recent Press Releases
IONS
From
Motley Fool
There's 'Outsized' Risk-Reward For This Biotech, Morgan Stanley Says, Predicting Shares Could Grow More Than 30%
September 09, 2022
Tickers
IONS
Tags
Upgrades
Benzinga
Biotech
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Tickers
ADCT
ALEC
ANNX
ARVN
Tags
COIN
Analyst Ratings
PRGS
From
Benzinga
Analyst Ratings for Ionis Pharmaceuticals
September 09, 2022
Tickers
IONS
Tags
Benzinga
Market News
IONS
From
Benzinga
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
September 07, 2022
Tickers
BCYC
DBVT
ERAS
GKOS
Tags
General
Small Cap
MCRB
From
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.